A New Phase of Biopharmaceuticals

PhaseBio is a clinical-stage biopharmaceutical company committed to developing new and improved biotherapeutics. We are leveraging our proprietary elastin-like polypeptide technology to advance a pipeline of novel drug candidates with the potential for less frequent dosing and better patient compliance. Our focus is on developing treatments for metabolic and specialty cardiopulmonary disorders.